Medicare Part D coverage · fluoxetine · RxCUI 313990
fluoxetine 10 MG Oral Tablet
Per the CMS 2026 Part D formulary file, fluoxetine 10 MG Oral Tablet is covered by 3,132 Medicare Part D plans (62% of enrollable products), averaging Tier 1.9, with prior authorization required on 0% of covering formularies.
- 62%
- Plan coverage
- 3,132
- Plans covering
- T1.9
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for fluoxetine 10 MG Oral Tablet
Per the CMS 2026 Part D formulary file, fluoxetine 10 MG Oral Tablet (RxNorm concept RXCUI 313990, generic name fluoxetine) appears on 78 distinct formulary files spanning 3,132 Medicare Part D plan offerings - 62% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.9.
Real-world access to fluoxetine 10 MG Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 26.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,427,221 Part D beneficiaries filled fluoxetine 10 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $104,943,337 and an average per-beneficiary annual cost of $73.53. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry fluoxetine 10 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 78
- Plans covering
- 3,132
- Coverage rate
- 62%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 26.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,427,221
- Total spending
- $104,943,337
- Avg per beneficiary
- $73.53
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering fluoxetine 10 MG Oral Tablet
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering fluoxetine 10 MG Oral Tablet
98 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | MO |
| UHC Dual Complete NE-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | NE |
| UHC Dual Complete KS-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | KS |
| UHC Dual Complete MO-S3 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | MO |
| UHC Dual Complete KS-Q1 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T1 | No | $0 | KS |
| UHC Dual Complete TN-S001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| UHC Dual Complete TN-Y001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| UHC Dual Complete TN-Y2 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T1 | No | $0 | TN |
| AARP Medicare Advantage from UHC MI-0001 (PPO) | Unitedhealthcare Insurance Company | T1 | No | $0 | MI |
| UHC Dual Complete NM-Y1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete NM-S1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete NM-V1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T1 | No | $0 | NM |
| UHC Dual Complete AZ-S001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | No | $0 | AZ |
| UHC Dual Complete AZ-Y001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T1 | No | $0 | AZ |
| UHC Dual Complete VA-Y4 (PPO D-SNP) | Care Improvement Plus South Central Insurance Co. | T1 | No | $0 | VA |
| AARP Medicare Advantage from UHC AL-0001 (HMO-POS) | Unitedhealthcare OF THE Midlands, Inc. | T1 | No | $0 | AL |
| AARP Medicare Advantage from UHC CA-0002 (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
| UHC Sharp Medicare Advantage CA-001P (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
| AARP Medicare Advantage from UHC CA-003P (HMO-POS) | UHC OF California | T1 | No | $0 | CA |
Show the next 30 plans
Showing top 50 of 98 plans.
Frequently Asked Questions
Is fluoxetine 10 MG Oral Tablet covered by Medicare Part D?
Yes, fluoxetine 10 MG Oral Tablet is covered by 3,132 Medicare Part D plans (62% of all Part D formularies).
What tier is fluoxetine 10 MG Oral Tablet on Medicare Part D plans?
fluoxetine 10 MG Oral Tablet averages Tier 1.9 across Part D plans, ranging from Tier 1 to Tier 4.
Does fluoxetine 10 MG Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for fluoxetine 10 MG Oral Tablet. Step therapy: 0%. Quantity limits: 26.9%.
How much does Medicare spend on fluoxetine 10 MG Oral Tablet?
In 2023, total Medicare Part D spending on fluoxetine 10 MG Oral Tablet was $104,943,337, covering 1,427,221 beneficiaries. The average spend per beneficiary was $73.53.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- methylprednisolone 8 MG Oral Tablet T1.9
- 24 HR diltiazem hydrochloride 300 MG Extended Release Oral Capsule [Tiadylt] T1.9
- 24 HR diltiazem hydrochloride 420 MG Extended Release Oral Capsule [Tiadylt] T1.9
- metaxalone 800 MG Oral Tablet T1.9
- tramadol hydrochloride 100 MG Oral Tablet T1.9
- cefuroxime 250 MG Oral Tablet T1.9
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA